NRX Pharmaceuticals Files Registration Statement for Sale of Stock by Shareholders

MT Newswires Live11-15

NRX Pharmaceuticals (NRXP) on Thursday filed a preliminary prospectus for the sale of up to 3,304,374 of the company's common stock from time to time by some of its shareholders.

The shares are issuable if the holders of the company's 6% senior secured note convert the debt into equity and exercise their warrants for stock in full.

The company identified the selling shareholders as Anson Investments Master Fund and Anson East Master Fund.

The company said it would not receive any proceeds from the resale of its shares.

Shares of NRX Pharmaceuticals were down 6.4% in recent trading.

Price: 1.17, Change: -0.08, Percent Change: -6.40

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483382093?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 01:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483382093","market":"nz","top_or_hot":-1,"title":"NRX Pharmaceuticals Files Registration Statement for Sale of Stock by Shareholders","media":"MT Newswires Live","content":"<html><body><p> NRX Pharmaceuticals (NRXP) on Thursday filed a preliminary prospectus for the sale of up to  3,304,374 of the company's common stock from time to time by some of its shareholders.</p><p>The shares are issuable if the holders of the company's 6% senior secured note convert the debt into equity and exercise their warrants for stock in full.</p><p>The company identified the selling shareholders as Anson Investments Master Fund and Anson East Master Fund.</p><p>The company said it would not receive any proceeds from the resale of its shares.</p><p>Shares of NRX Pharmaceuticals were down 6.4% in recent trading.</p><p>Price: 1.17, Change: -0.08, Percent Change: -6.40</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NRX Pharmaceuticals Files Registration Statement for Sale of Stock by Shareholders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNRX Pharmaceuticals Files Registration Statement for Sale of Stock by Shareholders\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 01:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NRX Pharmaceuticals (NRXP) on Thursday filed a preliminary prospectus for the sale of up to  3,304,374 of the company's common stock from time to time by some of its shareholders.The shares are ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NRXP","symbol_name":"NRX Pharmaceuticals Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2483382093","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483382093","pubTimestamp":1731606381,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"NRX Pharmaceuticals  on Thursday filed a preliminary prospectus for the sale of up to  3,304,374 of the company's common stock from time to time by some of its shareholders.The shares are issuable if the holders of the company's 6% senior secured note convert the debt into equity and exercise their warrants for stock in full.The company identified the selling shareholders as Anson Investments Master Fund and Anson East Master Fund.The company said it would not receive any proceeds from the resale of its shares.Shares of NRX Pharmaceuticals were down 6.4% in recent trading.Price: 1.17, Change: -0.08, Percent Change: -6.40","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NRXP":"NRX Pharmaceuticals Inc.","BK4007":"制药"},"translate_title":"NRX Pharmaceuticals提交股东出售股票登记声明","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NRXP":0.9},"content_text":"NRX Pharmaceuticals (NRXP) on Thursday filed a preliminary prospectus for the sale of up to  3,304,374 of the company's common stock from time to time by some of its shareholders.The shares are issuable if the holders of the company's 6% senior secured note convert the debt into equity and exercise their warrants for stock in full.The company identified the selling shareholders as Anson Investments Master Fund and Anson East Master Fund.The company said it would not receive any proceeds from the resale of its shares.Shares of NRX Pharmaceuticals were down 6.4% in recent trading.Price: 1.17, Change: -0.08, Percent Change: -6.40","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483382093"}